Functional differences between low- and high-affinity CD8+ T cells in the tumor environment

被引:61
作者
Bos, Rinke [1 ]
Marquardt, Kristi L. [1 ]
Cheung, Jocelyn [1 ]
Sherman, Linda A. [1 ]
机构
[1] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA
关键词
INTERFERON-GAMMA; NEGATIVE SELECTION; CANCER REGRESSION; SELF-ANTIGENS; GENE-THERAPY; LYMPHOCYTES; TOLERANCE; AVIDITY; IMMUNOTHERAPY; EXPANSION;
D O I
10.4161/onci.21285
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Weak T-cell antigen receptor (TCR)-ligand interactions are sufficient to activate naive CD8(+) T cells, but generally do not result in tumor eradication. How differences in TCR affinity affect the regulation of T-cell function in an immunosuppressive tumor environment has not been investigated. We have examined the functional differences of high-vs. low-affinity CD8(+) T cells and we observed that infiltration, accumulation, survival and cytotoxicity within the tumor are severely impacted by the strength of TCR-ligand interactions. In addition, high-affinity CD8(+) T cells were found to exhibit lower expression of inhibitory molecules including PD-1, LAG-3 and NKG2A, thus being less susceptible to suppressive mechanisms. Interferon. and autocrine interleukin-2 were both found to influence the level of expression of these molecules. Interestingly, although high-affinity CD8+ T cells were superior to low-affinity CD8(+) T cells in their ability to effect tumor eradication, they could be further improved by the presence of tumor specific CD4(+) T cells. These findings illustrate the importance of both TCR affinity and tumor-specific CD4 help in tumor immunotherapy.
引用
收藏
页码:1239 / 1247
页数:9
相关论文
共 41 条
[21]   Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer [J].
Matsuzaki, Junko ;
Gnjatic, Sacha ;
Mhawech-Fauceglia, Paulette ;
Beck, Amy ;
Miller, Austin ;
Tsuji, Takemasa ;
Eppolito, Cheryl ;
Qian, Feng ;
Lele, Shashikant ;
Shrikant, Protul ;
Old, Lloyd J. ;
Odunsi, Kunle .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (17) :7875-7880
[22]   Genetically modulating T-cell function to target cancer [J].
Merhavi-Shoham, Efrat ;
Haga-Friedman, Astar ;
Cohen, Cyrille J. .
SEMINARS IN CANCER BIOLOGY, 2012, 22 (01) :14-22
[23]   Induction of peripheral CD8+ T-cell tolerance by cross-presentation of self antigens [J].
Miller, JFAP ;
Kurts, C ;
Allison, J ;
Kosaka, H ;
Carbone, F ;
Heath, WR .
IMMUNOLOGICAL REVIEWS, 1998, 165 :267-277
[24]   Cancer regression in patients after transfer of genetically engineered lymphocytes [J].
Morgan, Richard A. ;
Dudley, Mark E. ;
Wunderlich, John R. ;
Hughes, Marybeth S. ;
Yang, James C. ;
Sherry, Richard M. ;
Royal, Richard E. ;
Topalian, Suzanne L. ;
Kammula, Udai S. ;
Restifo, Nicholas P. ;
Zheng, Zhili ;
Nahvi, Azam ;
de Vries, Christiaan R. ;
Rogers-Freezer, Linda J. ;
Mavroukakis, Sharon A. ;
Rosenberg, Steven A. .
SCIENCE, 2006, 314 (5796) :126-129
[25]   A critical role of T cell antigen receptor-transduced MHC class I-restricted helper T cells in tumor protection [J].
Morris, EC ;
Tsallios, A ;
Bendle, GM ;
Xue, SA ;
Stauss, HJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (22) :7934-7939
[26]   Characterization of CD8+ T lymphocytes that persist after peripheral tolerance to a self antigen expressed in the pancreas [J].
Nugent, CT ;
Morgan, DJ ;
Biggs, JA ;
Ko, A ;
Pilip, IM ;
Pamer, EG ;
Sherman, LA .
JOURNAL OF IMMUNOLOGY, 2000, 164 (01) :191-200
[27]   Does the immune system see tumors as foreign or self? [J].
Pardoll, D .
ANNUAL REVIEW OF IMMUNOLOGY, 2003, 21 :807-839
[28]   Interferon γ is required for activation-induced death of T lymphocytes [J].
Refaeli, Y ;
Van Parijs, L ;
Alexander, SI ;
Abbas, AK .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (07) :999-1005
[29]   Cancer immunotherapy: moving beyond current vaccines [J].
Rosenberg, SA ;
Yang, JC ;
Restifo, NP .
NATURE MEDICINE, 2004, 10 (09) :909-915
[30]  
Rozen S, 2000, Methods Mol Biol, V132, P365